AmerisourceBergen Pays $625M To Resolve Drug Repackaging False Claims Allegations

(October 2, 2018, 2:10 PM EDT) -- BROOKLYN, N.Y. — Drug wholesaler AmerisourceBergen Corp. and four subsidiaries have agreed to pay $625 million to resolve civil allegations that they improperly repackaged cancer drugs into prefilled syringes, resulting in...
To view the full article, register now.